Terms: = Ovarian cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Diagnosis
3 results:
1. Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; Primm K; Giordano SH; Meyer LA
Cancer; 2021 Nov; 127(22):4151-4160. PubMed ID: 34347287
[TBL] [Abstract] [Full Text] [Related]
2. A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer.
Beachler DC; Lamy FX; Russo L; Taylor DH; Dinh J; Yin R; Jamal-Allial A; Dychter S; Lanes S; Verpillat P
J Ovarian Res; 2020 Aug; 13(1):101. PubMed ID: 32867806
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive germline mutation analysis and clinical profile in a large cohort of Brazilian xeroderma pigmentosum patients.
Santiago KM; Castro LP; Neto JPD; de Nóbrega AF; Pinto CAL; Ashton-Prolla P; Pinto E Vairo F; de Medeiros PFV; Ribeiro EM; Ribeiro BFR; do Valle FF; Doriqui MJR; Leite CHB; Rocha RM; Moura LMS; Munford V; Galante PAF; Menck CFM; Rogatto SR; Achatz MI
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2392-2401. PubMed ID: 32239545
[TBL] [Abstract] [Full Text] [Related]
